Free alerts

LTRN insider buying

Every open-market purchase of Lantern Pharma Inc. (LTRN) stock by its officers, directors and major shareholders, from SEC Form 4 filings.

Bought, last 12 months$200K
Insiders buying (12m)2
Purchases on record2
Last purchase filedMay 14, 2026

In the last 12 months, 2 insiders of Lantern Pharma Inc. bought $200K of LTRN stock on the open market in 2 reported purchases. The most recent was filed on May 14, 2026: Schalop Lee Troy (Director) bought 48,544 shares at $2.06, worth $100K.

Get the next LTRN insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.

Join free on Telegram

All LTRN insider purchases

FiledInsiderValueSharesPriceStakeTrade
May 14Schalop Lee TroyDirector$100K48,544$2.06newMay 12SEC
May 14Keyser D JeffreyDirector$100K48,544$2.06+106%May 12SEC